Marc Dunoyer

Marc Dunoyer

Chief Executive Officer at ALEXION PHARMACEUTICALS, INC.
73 year
Health Technology
Consumer Services
Consumer Non-Durables

Profile

Marc Pierre Jean Dunoyer is Chief Financial Officer & Executive Director at AstraZeneca Plc and on the board of 5 other companies. He previously occupied the position of Global Head-Rare Diseases Unit at GlaxoSmithKline Plc and Chairman of GlaxoSmithKline KK (a subsidiary of GlaxoSmithKline Plc) and President-Asia Pacific at Hoechst Marion Roussel SA. He received an MBA from Hautes Etudes Commerciales and a graduate degree from Université de Paris IV Paris-Sorbonne.

Marc Dunoyer active positions

CompaniesPositionStart
ASTRAZENECA PLC Corporate Officer/Principal 2021-07-31
ALEXION PHARMACEUTICALS, INC. Chief Executive Officer -
CELLECTIS S.A. Director/Board Member 2024-05-05
JCR PHARMACEUTICALS CO., LTD. Director/Board Member 2023-05-31
Director/Board Member 2013-11-28
Alexion Pharmaceuticals, Inc. /New/
Chief Executive Officer 2021-07-31
Chairman -
Director/Board Member -
Director/Board Member 2018-06-06
░░░░░░ ░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ -

Former positions of Marc Dunoyer

CompaniesPositionEnd
░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Marc Dunoyer's experience

Training of Marc Dunoyer

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

64

1st degree connections

16

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies16

Health Technology

Health Technology

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Alexion Pharmaceuticals, Inc. /New/

Consumer Services